The Role of Thermogenesis in Antipsychotic Drug‐induced Weight Gain
- 1 January 2009
- Vol. 17 (1), 16-24
- https://doi.org/10.1038/oby.2008.468
Abstract
The administration of antipsychotic drugs to human patients or experimental animals leads to significant weight gain, which is widely presumed to be driven by hyperphagia; however, the contribution from energy expenditure remains unclear. These studies aim to examine the contribution of shifts in energy expenditure, particularly those involving centrally mediated changes in thermogenesis, to the body weight gain associated with the administration of olanzapine to female Sprague Dawley rats. Olanzapine (6 mg/kg/day orally) caused a transient increase in food intake but a maintained increase in body weight. When pair-fed rats were treated with olanzapine, body weight continued to rise compared to vehicle-treated rats, consistent with a reduction in energy expenditure. Brown adipose tissue (BAT) temperature, measured using biotelemetry devices, decreased immediately after the onset of olanzapine treatment and remained depressed, as did physical activity. UCP1 expression in interscapular BAT was reduced following chronic olanzapine treatment. An acute injection of olanzapine was preceded by an injection of a retrograde tracer into the spinal cord to evaluate the nature of the olanzapine-activated neural pathway. Levels of Fos protein in a number of spinally projecting neurons within discrete hypothalamic and brainstem sites were elevated in olanzapine-treated rats. Some of these neurons in the perifornical region of the lateral hypothalamus (LHA) were also Orexin A positive. These data collectively show a significant impact of thermogenesis (and physical activity) on the weight gain associated with olanzapine treatment. The anatomical studies provide an insight into the central neuroanatomical substrate that may subserve the altered thermogenic responses brought about by olanzapine.Keywords
This publication has 49 references indexed in Scilit:
- Antipsychotic drug-induced weight gain mediated by histamine H1receptor-linked activation of hypothalamic AMP-kinaseProceedings of the National Academy of Sciences of the United States of America, 2007
- The role of brown adipose tissue in human obesityNutrition, Metabolism and Cardiovascular Diseases, 2006
- Energy Expenditure and Physical Activity in Clozapine use: Implications for Weight ManagementAustralian & New Zealand Journal of Psychiatry, 2006
- Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medicationJournal of the American Dietetic Association, 2005
- Orexins induce increased Excitability and Synchronisation of Rat Sympathetic Preganglionic NeuronesThe Journal of Physiology, 2003
- Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in humanPharmacology Biochemistry and Behavior, 2003
- Binding of antipsychotic drugs to human brain receptors: Focus on newer generation compoundsLife Sciences, 2000
- Weight gain associated with psychotropic drugsExpert Opinion on Pharmacotherapy, 2000
- From Lesions to Leptin: Hypothalamic Control of Food Intake and Body WeightNeuron, 1999
- Immunohistochemical detection of human brown adipose tissue uncoupling protein in an autopsy series.Journal of Histochemistry & Cytochemistry, 1993